Cargando…
Benzydamine hydrochloride for the treatment of sore throat and irritative/inflammatory conditions of the oropharynx: a cross-national survey among pharmacists and general practitioners
BACKGROUND: Benzydamine for oromucosal use is indicated in the relief of pain and irritation of the mouth and throat. It is an indazole derivative, non-steroidal anti-inflammatory drug, with combined local anesthetic and analgesic properties, and antiseptic activity, marketed under the brand name “T...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205545/ https://www.ncbi.nlm.nih.gov/pubmed/35715725 http://dx.doi.org/10.1186/s12875-022-01762-3 |
_version_ | 1784729156281434112 |
---|---|
author | Passali, Desiderio Arezzo, Maria Felice De Rose, Alessandra De Simone, Gianmarco Forte, Gianluigi Jablko-Musial, Michalina Mösges, Ralph |
author_facet | Passali, Desiderio Arezzo, Maria Felice De Rose, Alessandra De Simone, Gianmarco Forte, Gianluigi Jablko-Musial, Michalina Mösges, Ralph |
author_sort | Passali, Desiderio |
collection | PubMed |
description | BACKGROUND: Benzydamine for oromucosal use is indicated in the relief of pain and irritation of the mouth and throat. It is an indazole derivative, non-steroidal anti-inflammatory drug, with combined local anesthetic and analgesic properties, and antiseptic activity, marketed under the brand name “Tantum Verde”. The aim of this study was to explore knowledge and prescriptive/advising attitudes among general practitioners (GPs) and pharmacists (PHs) with regard to the topical treatment of sore throat and other irritative/inflammatory conditions of the oropharynx, with a focus on benzydamine. These findings could be important to increase awareness on benzydamine efficacy in sore throat and stomatological conditions, and to reinforce knowledge on the characteristics of benzydamine and its mechanisms of action among healthcare professionals (pediatricians, otolaryngologists, oncologists, etc.). MATERIALS AND METHODS: An online questionnaire survey was performed among PHs and GPs in four European countries (Italy, Germany, Russia and Poland). RESULTS: Both GPs and PHs proved to have an excellent knowledge and mastery of the constituents effective against oral symptoms. Among all the principles, benzydamine hydrochloride is the most recognized as certainly suitable for the topical treatment of sore throat symptoms and various inflammatory/irritative conditions of the oral cavity. It is recommended by about 90% of PHs and prescribed by 80% of GPs, mainly to solve the ailments caused by sore throats and stomatitis, especially for its anti-inflammatory, analgesic and anesthetic characteristics. Also in the pediatric field, benzydamine hydrochloride is recommended: among GPs, a high percentage (about 40%) prescribes it like the remedies based on dichlorobenzyl alcohol-sodium benzoate, which are instead more often recommended by PHs (44% against 37%). CONCLUSION: Although the public has a lot of confidence in this treatment, GPs and PHs do not recommend/prescribe benzydamine as a first-line treatment of sore throat and other irritative/inflammatory conditions of the oropharynx. To increase the knowledge of benzydamine among these healthcare professionals, it would be important to emphasize its characteristics and the different irritative/inflammatory conditions of the oropharynx in which it can be used. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12875-022-01762-3. |
format | Online Article Text |
id | pubmed-9205545 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-92055452022-06-19 Benzydamine hydrochloride for the treatment of sore throat and irritative/inflammatory conditions of the oropharynx: a cross-national survey among pharmacists and general practitioners Passali, Desiderio Arezzo, Maria Felice De Rose, Alessandra De Simone, Gianmarco Forte, Gianluigi Jablko-Musial, Michalina Mösges, Ralph BMC Prim Care Research BACKGROUND: Benzydamine for oromucosal use is indicated in the relief of pain and irritation of the mouth and throat. It is an indazole derivative, non-steroidal anti-inflammatory drug, with combined local anesthetic and analgesic properties, and antiseptic activity, marketed under the brand name “Tantum Verde”. The aim of this study was to explore knowledge and prescriptive/advising attitudes among general practitioners (GPs) and pharmacists (PHs) with regard to the topical treatment of sore throat and other irritative/inflammatory conditions of the oropharynx, with a focus on benzydamine. These findings could be important to increase awareness on benzydamine efficacy in sore throat and stomatological conditions, and to reinforce knowledge on the characteristics of benzydamine and its mechanisms of action among healthcare professionals (pediatricians, otolaryngologists, oncologists, etc.). MATERIALS AND METHODS: An online questionnaire survey was performed among PHs and GPs in four European countries (Italy, Germany, Russia and Poland). RESULTS: Both GPs and PHs proved to have an excellent knowledge and mastery of the constituents effective against oral symptoms. Among all the principles, benzydamine hydrochloride is the most recognized as certainly suitable for the topical treatment of sore throat symptoms and various inflammatory/irritative conditions of the oral cavity. It is recommended by about 90% of PHs and prescribed by 80% of GPs, mainly to solve the ailments caused by sore throats and stomatitis, especially for its anti-inflammatory, analgesic and anesthetic characteristics. Also in the pediatric field, benzydamine hydrochloride is recommended: among GPs, a high percentage (about 40%) prescribes it like the remedies based on dichlorobenzyl alcohol-sodium benzoate, which are instead more often recommended by PHs (44% against 37%). CONCLUSION: Although the public has a lot of confidence in this treatment, GPs and PHs do not recommend/prescribe benzydamine as a first-line treatment of sore throat and other irritative/inflammatory conditions of the oropharynx. To increase the knowledge of benzydamine among these healthcare professionals, it would be important to emphasize its characteristics and the different irritative/inflammatory conditions of the oropharynx in which it can be used. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12875-022-01762-3. BioMed Central 2022-06-17 /pmc/articles/PMC9205545/ /pubmed/35715725 http://dx.doi.org/10.1186/s12875-022-01762-3 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Passali, Desiderio Arezzo, Maria Felice De Rose, Alessandra De Simone, Gianmarco Forte, Gianluigi Jablko-Musial, Michalina Mösges, Ralph Benzydamine hydrochloride for the treatment of sore throat and irritative/inflammatory conditions of the oropharynx: a cross-national survey among pharmacists and general practitioners |
title | Benzydamine hydrochloride for the treatment of sore throat and irritative/inflammatory conditions of the oropharynx: a cross-national survey among pharmacists and general practitioners |
title_full | Benzydamine hydrochloride for the treatment of sore throat and irritative/inflammatory conditions of the oropharynx: a cross-national survey among pharmacists and general practitioners |
title_fullStr | Benzydamine hydrochloride for the treatment of sore throat and irritative/inflammatory conditions of the oropharynx: a cross-national survey among pharmacists and general practitioners |
title_full_unstemmed | Benzydamine hydrochloride for the treatment of sore throat and irritative/inflammatory conditions of the oropharynx: a cross-national survey among pharmacists and general practitioners |
title_short | Benzydamine hydrochloride for the treatment of sore throat and irritative/inflammatory conditions of the oropharynx: a cross-national survey among pharmacists and general practitioners |
title_sort | benzydamine hydrochloride for the treatment of sore throat and irritative/inflammatory conditions of the oropharynx: a cross-national survey among pharmacists and general practitioners |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205545/ https://www.ncbi.nlm.nih.gov/pubmed/35715725 http://dx.doi.org/10.1186/s12875-022-01762-3 |
work_keys_str_mv | AT passalidesiderio benzydaminehydrochlorideforthetreatmentofsorethroatandirritativeinflammatoryconditionsoftheoropharynxacrossnationalsurveyamongpharmacistsandgeneralpractitioners AT arezzomariafelice benzydaminehydrochlorideforthetreatmentofsorethroatandirritativeinflammatoryconditionsoftheoropharynxacrossnationalsurveyamongpharmacistsandgeneralpractitioners AT derosealessandra benzydaminehydrochlorideforthetreatmentofsorethroatandirritativeinflammatoryconditionsoftheoropharynxacrossnationalsurveyamongpharmacistsandgeneralpractitioners AT desimonegianmarco benzydaminehydrochlorideforthetreatmentofsorethroatandirritativeinflammatoryconditionsoftheoropharynxacrossnationalsurveyamongpharmacistsandgeneralpractitioners AT fortegianluigi benzydaminehydrochlorideforthetreatmentofsorethroatandirritativeinflammatoryconditionsoftheoropharynxacrossnationalsurveyamongpharmacistsandgeneralpractitioners AT jablkomusialmichalina benzydaminehydrochlorideforthetreatmentofsorethroatandirritativeinflammatoryconditionsoftheoropharynxacrossnationalsurveyamongpharmacistsandgeneralpractitioners AT mosgesralph benzydaminehydrochlorideforthetreatmentofsorethroatandirritativeinflammatoryconditionsoftheoropharynxacrossnationalsurveyamongpharmacistsandgeneralpractitioners |